Paper 43 - MANAGEMENT OF THE DUODENUM DURING RESECTION OF PRIMARY RETROPERITONEAL SARCOMA: SURGICAL AND ONCOLOGICAL OUTCOMES FROM A MULTICENTER STUDY.

Author(s)

• 

  Alessandra Borghi, MD

  Surgeon
  Fondazione IRCCS Istituto Nazionale dei Tumori
  Milan, Lombardia, Italy

Co-Author(s)

• GT

  Gabriele Tinè, MSc

  Biostatistician
  Fondazione IRCCS Istituto Nazionale dei Tumori, Mialno
  Milan, Lombardia, Italy
• RM

  Rosalba Miceli, MD (she/her/hers)

  Biostatistician
  Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan
  Milano, Lombardia, Italy
• 

  Marco Fiore, MD, FACS, FEBS

  Surgeon
  Fondazione IRCCS Istituto Nazionale dei Tumori
  Milano, Lombardia, Italy
• 

  Carol J. Swallow, MD, PhD

  Professor
  Princess Margaret Cancer Centre, University Health Network and Mount Sinai Hospital
  Toronto, Ontario, Canada
• Wj

  Wendy johnston, PhD

  Princess Margaret Cancer Centre, University Health Network and Mount Sinai Hospital
  Toronto, Ontario, Canada
• DC

  David J Coker, MD

  Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
  Camperdown, New South Wales, Australia
• MR

  Michael Russell, MD

  North Island Sarcoma Service, Auckland City Hospital, Auckland, New Zealand.
  Auckland, Auckland, New Zealand
• 

  Dirk Strauss, FCS, FRCS

  Consultant
  The Royal Marsden Hospital NHS Foundation Trust
  London, England, United Kingdom
• 

  Alessandro Gronchi, MD (he/him/his)

  Surgical Oncologist
  Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan
  Milano, Lombardia, Italy
• 

  Dario Callegaro, MD (he/him/his)

  Surgical Oncologist
  Fondazione IRCCS IStituto Nazionale dei Tumori, Milan, Italy
  Milan, Lombardia, Italy